Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 232 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-11-06 | 2024-03-01 | 209363 |
APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210701 |
APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2024-01-05 | 2024-02-02 | 215221 |
APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-01-05 | 2024-03-08 | 215227 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-19 | 2024-02-09 | 216662 |
APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2024-02-09 | 2024-05-24 | 219162 |
APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-12 | 223043 |
APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-04-19 | 2024-05-31 | 225773 |
APO-WARFARIN | 2.5MG | TABLET | Actual shortage | 2024-05-31 | 2024-05-31 | 229419 |
APO-CROMOLYN NASAL SPRAY | 2% | SOLUTION SPRAY | Actual shortage | 2017-08-13 | 2017-10-05 | 19051 |
APO-FAMOTIDINE TAB 20MG USP | 20 MG | TABLET | Resolved | 2017-03-11 | 2018-09-09 | 619 |
APO-OXYCODONE CR | 20.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-11 | 2017-05-24 | 423 |
APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2017-05-10 | 2017-06-05 | 9954 |
APO-OXYCODONE CR | 20.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-10-11 | 2018-03-13 | 25304 |
APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2018-02-01 | 2018-05-25 | 37997 |
APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2019-02-06 | 2019-03-29 | 74917 |
APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2019-05-15 | 2019-06-24 | 84128 |
APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2020-04-13 | 2020-06-02 | 111925 |
APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2020-07-29 | 2020-12-17 | 121334 |
APO-OXYCODONE CR | 20.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-09 | 2023-01-26 | 177612 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |